3-122183002-G-A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The variant allele was found at a frequency of 0.612 in 152,010 control chromosomes in the GnomAD database, including 28,784 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.61 ( 28784 hom., cov: 33)

Consequence

Unknown

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -2.16

Publications

25 publications found
Variant links:

Genome browser will be placed here

ACMG classification

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 3-122183002-G-A is Benign according to our data. Variant chr3-122183002-G-A is described in ClinVar as Benign. ClinVar VariationId is 1167241.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.726 is higher than 0.05.

Variant Effect in Transcripts

 

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

Frequencies

GnomAD3 genomes
AF:
0.612
AC:
92881
AN:
151890
Hom.:
28752
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.580
Gnomad AMI
AF:
0.662
Gnomad AMR
AF:
0.737
Gnomad ASJ
AF:
0.627
Gnomad EAS
AF:
0.373
Gnomad SAS
AF:
0.463
Gnomad FIN
AF:
0.574
Gnomad MID
AF:
0.668
Gnomad NFE
AF:
0.635
Gnomad OTH
AF:
0.630
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.612
AC:
92961
AN:
152010
Hom.:
28784
Cov.:
33
AF XY:
0.611
AC XY:
45397
AN XY:
74298
show subpopulations
African (AFR)
AF:
0.580
AC:
24032
AN:
41446
American (AMR)
AF:
0.738
AC:
11287
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.627
AC:
2174
AN:
3470
East Asian (EAS)
AF:
0.373
AC:
1930
AN:
5170
South Asian (SAS)
AF:
0.464
AC:
2231
AN:
4810
European-Finnish (FIN)
AF:
0.574
AC:
6049
AN:
10536
Middle Eastern (MID)
AF:
0.663
AC:
195
AN:
294
European-Non Finnish (NFE)
AF:
0.635
AC:
43144
AN:
67966
Other (OTH)
AF:
0.624
AC:
1315
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1828
3656
5483
7311
9139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
766
1532
2298
3064
3830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.616
Hom.:
13001
Bravo
AF:
0.625
Asia WGS
AF:
0.392
AC:
1365
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Autosomal dominant hypocalcemia 1;C1809471:Familial hypocalciuric hypercalcemia Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.34
DANN
Benign
0.59
PhyloP100
-2.2

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6776158; hg19: chr3-121901849; API